Miso Clinic · Clinical column

Density or XERF: which to choose — How to choose when there is no comparative study

Miso Clinic has both Density and XERF, so we are often asked, “Which of the two is better?” The honest answer is “there is no comparative data to say one is better.” That does not mean picking either at random. Match the design difference between the two devices to the conditions of the face, and which to put first is usually settled. I have written down those criteria.

Clinical column About 5 min October 2026 Miso Clinic, Daegu · Dr. Lee Chi-Hak, Medical Director

The short answer

Choosing between Density and XERF is not about which is superior but about matching design to the conditions of the face — there is no human study comparing the two directly. Density fires monopolar then bipolar to heat by depth; XERF splits areas with two frequencies and tips of different sizes. So if the skin is thick and sagging deep we consider Density first, and if areas need splitting or you want less anaesthesia burden, XERF first. Miso Clinic in Daegu (4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, +82-53-428-2700) has both devices and decides which to put first by four things: skin thickness · depth of sagging · area · anaesthesia burden (clinical judgement).

Which is better, Density or XERF?

There is no basis for saying one is better. A systematic review of 15 RF device studies covering 1,230 people found only one randomised controlled trial and wrote that no head-to-head device comparisons were found (ASJ Open Forum 2026). The 16-person Density study and the three XERF studies all lack control groups, so their numbers cannot be set side by side either.

So this piece is not about “which one wins” but the criteria for “which to put first on which face.” All judgements below are Miso Clinic’s clinical judgement.

How do the two devices differ in design?

Design of Density and XERF (manufacturers’ published material)
ItemDensityXERF
ManufacturerJeisys MedicalLutronic
MethodSequential monopolar → bipolarMonopolar
How depth is handledDeep layer → shallow layer in one passTwo frequencies (6.78 MHz · 2 MHz) chosen to suit the area
TipALPHA · Eye · Face · Bodyi05 · i10 · E40 · E60 (four sizes of different area)
Epidermal protection5-level gas cooling, real-time temperatureSee manufacturer material
Human studies16 people · one session · 24 weeksThree studies of 20 · 39 · 16 people, longest 90 days · 3 months
Control groupNoneNone in all three

A different design means “the situations it suits may differ,” not that different results have been confirmed.

How do you decide by skin thickness and sagging depth?

If the skin is relatively thick and the sagging deep, we consider Density first (clinical judgement), because it is designed to handle the deep layer with monopolar and the shallow layer with the following bipolar in one go. We also tell you there is no study showing Density results were better in thick skin.

Skin thickness is hard to guess from appearance. Superficial fat varied widely between people at 5.2 ± 1.9 mm (Lee 2021), and the more the submental area sagged, the thinner the skin and the thicker the superficial fat (Kwon 2022). Thickness also differs by area within the same face, so Miso Clinic decides after checking by palpation and measurement. If your skin is on the thin side and you are worried about heat treatment, see Lifting thin skin: what to watch for.

What about faces where areas need splitting?

For faces where narrow areas like around the eyes · mouth need settings separate from the cheeks · jawline, we consider XERF first (clinical judgement). XERF is designed with swappable tips of different areas from 5×10 mm to 20×30 mm. Density also has an Eye tip for around the eyes, so this one condition does not decide it.

There is one human study comparing only tip size (Yang 2024, 31 people, split face). The difference between the two tips was not statistically significant (p=0.845), and it was not a study comparing the two devices. So rather than the device name, we look at what size of tip reaches that area evenly (clinical judgement).

How do pain and anaesthesia compare?

Going by numbers alone, Density is 1.4 and XERF in the 4s. But these two numbers cannot be compared. The Density study used a 5-point scale (Oku 2025) and the XERF studies a 10-point scale (Weiss 2026 4.2 · Erlich 2026 4.31), and anaesthesia conditions, settings and subjects differed too.

At Miso Clinic, Density uses numbing cream depending on area and setting, and XERF is mostly done without anaesthesia. If one device was hard for you before, a realistic criterion is to try the other first (clinical judgement). Either way, we do not use anaesthesia that completely blocks the pain signal — it has been pointed out that strong anaesthesia masks the signal of heat injury (Narins 2006).

What about when neither Density nor XERF comes first?

What we look at first instead of either device (clinical judgement)
This kind of faceLook at firstReason
The skin has thinned and there is deep sagging tooOligio Kiss or a sequenced RF + booster designThere are two layers to treat
Sagging tissue needs to be physically hooked and liftedThread liftTightening with heat and moving position are different
Hollow cheeks · templesFillers — Lifting a face with hollow cheeksHeat does not create volume
Thin, dull skin without saggingBoosters — Skin boosters in Daegu: where to startIt is a matter of dermal material
Loose enough for the skin to foldSurgical consultationIt is beyond the non-invasive range

If you are weighing it against ultrasound lifting, see How ultrasound (HIFU) and RF differ; for the difference from Thermage, see How Density and Thermage differ. Miso Clinic does not have Thermage or Ulthera.

In what order is it decided at consultation?

  1. 1What has changedWe identify the main concern among texture · sagging · hollowing · fat.
  2. 2Whether RF suits the problemIf hollowing · thin skin is the main problem, we go to another method here.
  3. 3Skin thickness and sagging depthIf the skin is thick and the sagging deep, we put Density first.
  4. 4Area and anaesthesia burdenIf areas need splitting or no anaesthesia matters, we put XERF first.
  5. 5Judge at 2–3 monthsIn an RF study, clinical assessment was significant at 12 weeks. After that we decide what is next.

We have not found comparative data showing that combining the two devices on the same day is better than either alone. So the default is to start with one device and decide what is next after seeing the course (clinical judgement).

Choosing Density or XERF: frequently asked questions

Which works better, Density or XERF?

There is no human study comparing the two devices directly, so there is no basis to rank them. A systematic review of 15 RF device studies also found no head-to-head device comparisons.

Which one if the skin is thick?

If the skin is relatively thick and the sagging deep, we consider Density first. This is because of its design that heats by depth; there is no study showing better results in thick skin. It is clinical judgement.

Which one if I want the eye area done too?

If areas need separate settings, we tend to consider XERF first. Density also has an Eye tip, so this condition alone does not decide it.

Which one hurts less?

Density 1.4 (5-point scale) and XERF in the 4s (10-point scale) use different scales and conditions, so they cannot be compared. If one was hard for you before, trying the other first is realistic.

Is it better to have Density and XERF together?

We have not found comparative data showing that combining them on the same day is better than either alone. Miso Clinic starts with one device and decides what is next after seeing the course two to three months later.

Where can I get a Density · XERF consultation in Daegu?

Miso Clinic in Daegu is at 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, in front of Exit 1 of Kyungpook National University Hospital Station. +82-53-428-2700; weekdays 11:00–19:00 · Saturday 10:00–16:00 (no lunch break); closed Sundays · public holidays.

Clinical columns to read next

Product reference

Related material: Density · XERF product references

Clinic

This column was written and reviewed by Lee Chi-Hak, MD, medical director of Miso Clinic in Daegu. The treatment criteria and injection design are written exactly as we actually use them.

Miso Clinic
Medical DirectorLee Chi-Hak, MD
Address4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu (Exit 1, Kyungpook National University Hospital Station) · tower parking in the building
Phone053-428-2700
KakaoTalk consultationMiso Clinic Daegu channel
KakaoTalk channelAdd the channel
Opening hoursWeekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays
Clinical columnSee all columns
Reference libraryAll booster and lifting device references

References

  1. Evidence comparing RF devices — Aesthetic Surgery Journal Open Forum 2026 systematic review (15 studies · 1,230 people, 1 randomised controlled trial). States that no head-to-head device comparisons were found.
  2. Density specifications — Jeisys Medical published material: sequential monopolar → bipolar delivery, up to 400 W, RIC automatic impedance adjustment, 5-level gas cooling, real-time skin temperature, tips ALPHA 600 · Eye 600 · Face 1,000 · Body 600 shots (guaranteed shot counts). MFDS-approved medical device; approval number not confirmed in the original.
  3. Human study of Density — Oku K, J Cosmet Dermatol 2025;24(10):e70504, PMID 41090512. 16 adults · one session · 24 weeks · no control group. 3D imaging tightening distance 0.82 ± 0.36 mm, pain 1.4 ± 0.6 (5-point scale).
  4. XERF specifications — Lutronic published material: monopolar, 6.78 MHz + 2 MHz, handpieces i05 (5×10 mm · 400 shots) · i10 (10×10 mm · 300 shots) · E40 (20×20 mm · 600 shots) · E60 (20×30 mm · 600 shots). Korean approval classification: general-purpose electrosurgical unit; advertising review “General-purpose electrosurgical unit association-2024-16-054”.
  5. Three human studies of XERF — Hwang JK, Medical Lasers 2025;14(1):23–30 (20 people · one session · 12 weeks) · Weiss RA et al., Cureus 2026;18(3):e104546, PMID 41930066 (39 people · two sessions · 90 days, manufacturer-supported) · Erlich G et al., Lasers Med Sci 2026;41(1), PMID 42611100 (retrospective 16 people · one session · 3 months). None of the three had a control group.
  6. Individual variation in facial layer thickness — Lee KW et al., Clinical Anatomy 2021;34(7):1050–1058, PMID 33583088. 3D measurement of 30 fixed cadavers; skin 2.1 ± 0.4 mm, superficial fat 5.2 ± 1.9 mm.
  7. Ultrasound of lower-face layer structure — Kwon SH et al., Dermatologic Surgery 2022;48(5):527–531, PMID 35093961. Retrospective review of 200 people. Sagging submental areas had thinner skin and thicker superficial fat.
  8. Split-face trial of electrode size — Yang YS et al., J Clin Aesthet Dermatol 2024. 31 people, 3 cm² vs 4 cm² tip. The comparison between the two tips was p=0.845, not significant; the p < 0.001 in the paper is the before-after comparison. Not a Density · XERF study.
  9. Fat atrophy — Narins RS et al., Dermatol Surg 2006;32:115–124. Appears at 1–4 months (average 2 months), about 4 per 10,000 treatments. Notes that strong anaesthesia blocks pain feedback.
  10. Timeline of RF results — Cosmetics 2024;11(3):71 (20 Korean women: clinical assessment not significant at 4 weeks · significant at 12 · 24 weeks; device-measured elasticity from 4 weeks) · Weiss 2026 (84.6% at 30 days → 92.3% at 90 days) · Fitzpatrick 2003 and Edwards AF et al., Dermatol Surg 2013;39:104–110 (peak at 4–6 months). None had a control group.
  11. Korean medical advertising law — Medical Service Act Article 56(2), which prohibits testimonial advertising, comparison with other medical institutions and superlative claims.
  12. Miso Clinic clinical guidelines — criteria for indications, design by area, pre-treatment explanation and consent. The source of sentences marked “clinical judgement” in this column.

Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.

← Clinical columns · Reference library · Miso Clinic home

한국어 · English · 日本語